ArticleFrontiers in immunology2019

Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma.

Bettina Hohberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.